News and Trends 20 Oct 2022
Alvotech and JAMP Pharma add two biosimilar candidates for Canadian market
Alvotech and the JAMP Pharma Group have expanded their exclusive partnership to commercialize biosimilars developed and manufactured by Alvotech. The companies have added two biosimilar candidates from Alvotech's pipeline: AVT16,…